1,150 results on '"Richette, P."'
Search Results
202. THU0437 SPECIFIC COMORBIDITIES ENHANCE MONOSODIUM URATE CRYSTAL DEPOSITION IN GOUT: A MULTICENTRE DUAL-ENERGY COMPUTED TOMOGRAPHY STUDY
203. THU0422 CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION WITHIN TOPHUS LOBULE: A FREQUENT ASSOCIATION OBSERVED IN LONG-TIME COURSE TOPHI
204. OP0036 METHOTREXATE AND RHEUMATOID ARTHRITIS ASSOCIATED INTERSTITIAL LUNG DISEASE
205. SERPINA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leukocyte elastase
206. Postoperative spondylodiscitis due to Kytococcus schroeteri in a diabetic woman
207. Cartilage articulaire normal : anatomie, physiologie, métabolisme, vieillissement
208. Cartílago articular normal: anatomía, fisiología, metabolismo y envejecimiento
209. Excès de variants rares délétères au sein de gènes appartenant à la voir JAK-STAT chez des patients atteints de pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde
210. Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease adamts-5 expression in interleukin 1β-treated chondrocytes
211. Determinants of patient-reported psoriatic arthritis impact of disease: an analysis of the association with gender in 458 patients from 14 countries
212. Les infiltrations de corticoïdes et d'acide hyaluronique modifient-elles le risque de chirurgie prothétique dans la gonarthrose? Données à 5 ans de la cohorte KHOALA
213. Les recommandations de la SFR sur la prise en charge pharmacologique de la gonarthrose
214. Dual effects of 17β-oestradiol on interleukin 1β-induced proteoglycan degradation in chondrocytes
215. Dual effects of 17β-oestradiol on interleukin lβ-induced proteoglycan degradation in chondrocytes
216. MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease
217. SUA levels should not be maintained < 3 mg/dL for several years. Response to 'EULAR gout treatment guidelines by Richette et al: uric acid and neurocognition by Singh et al'
218. PAPASH , Ps APASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens
219. Do corticosteroids or hyaluronic acid intra-articular injections impact the risk of total knee replacement? Real-life data from the khoala cohort
220. Recommendations of the French society of rheumatology for the pharmacological management of knee osteoarthritis
221. Comparison of general practitioners and rheumatologists' prescription patterns for patients with knee osteoarthritis
222. MRI Features Associated With the Detection of Microbial Pathogens by CT-Guided Biopsy in Septic Spondylodiscitis
223. Syndromes PAPASH, PsAPASH et PASS : hétérogénéité phénotypique, signature biologique commune, intérêt des thérapeutiques immunosuppressives
224. Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients
225. Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice
226. Les traitements en cours de développement dans l'arthrose.
227. Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort.
228. Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)
229. Use of Intra-Articular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice
230. Use of intra-articular hyaluronic acid in management of knee osteoarthritis in clinical practice
231. Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial.
232. Iterative percutaneous needle aponeurotomy for Dupuytren's disease: Functional results at 5-year follow-up
233. SAT0553 Chondrocalcinosis of the knee and the risk for knee or hip osteoarthritis progression: data from the khoala cohort
234. THU0271 Emergence of severe spondyloarthropathy related entheseal pathology following vedolizumab therapy for inflammatory bowel disease
235. OP0357 Hyperechoic deposits in the renal medulla are associated with severe gout and decreased egfr: a transversal study in 503 vietnamese patients
236. OP0189 Identification of new and rare variants in abcg2, slc22a1 and aldh16a1 genes in crystal-proven early-onset gout
237. AB0983 Hyaluronan derivative hymovis® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from mokha study
238. FRI0235 Effect of serum uric acid (SUA) on gout flares (GF) and tophi resolution in gout patients. pooled post hoc analysis of clear 1 & clear 2 trials
239. FRI0182 Erosions at the sacroiliac joints and fatty lesions at the spine are the most discriminant lesions for recent onset axspa recognition
240. SAT0389 Mri predictive factors for positive ct-guided biopsy in suspected septic spondylodiscitis
241. THU0237 Inflammatory lesions of the sacroiliac joints, but not of the spine, are of high utility for axspa recognition: results of the ilos-desir study
242. FRI0227 Risk factors for skin reactions to allopurinol in the kinh population of vietnam
243. Hyaluronan derivative Hymovis® increases cartilage volume and type II collagen turnover in osteoarhritic knee: data from Mokha study
244. Chondrocalcinosis of the knee and the risk for knee or hip osteoarthritis progression: data from the Khoala cohort
245. Blockage of sphingosin 1 phosphate S1P/S1PR pathway prevents from osteoarthritis in mice by reducing chondrocyte catabolism
246. Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases
247. Effectiveness of topical sodium thiosulfate for ectopic calcifications and ossifications. Results of the CATSS-O study.
248. Erratum to: Effect of music on anxiety and pain during joint lavage for knee osteoarthritis
249. DOMAINS IMPACTING MINIMAL DISEASE ACTIVITY NON-ACHIEVEMENT IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO TNFI RECEIVING GUSELKUMAB (COSMOS).
250. PATIENTS ARE ALWAYS RIGHT! ASSOCIATION BETWEEN HUMIDITY LEVEL AND PAIN EXPERIENCE IN HAND OSTEOARTHRITIS.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.